Medicon Hellas S.A. (ATH:MEDIC)

Medicon Hellas Statistics

Total Valuation

Medicon Hellas has a market cap or net worth of EUR 11.14 million. The enterprise value is 11.80 million.

Market Cap	11.14M
Enterprise Value	11.80M

Important Dates

The next estimated earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	Jul 4, 2025

Share Statistics

Medicon Hellas has 4.42 million shares outstanding.

Current Share Class	4.42M
Shares Outstanding	4.42M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.41%
Float	n/a

Valuation Ratios

The trailing PE ratio is 6.00.

PE Ratio	6.00
Forward PE	n/a
PS Ratio	0.60
PB Ratio	0.58
P/TBV Ratio	0.58
P/FCF Ratio	29.72
P/OCF Ratio	9.57
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.08, with an EV/FCF ratio of 31.49.

EV / Earnings	6.22
EV / Sales	0.64
EV / EBITDA	3.08
EV / EBIT	5.31
EV / FCF	31.49

Financial Position

The company has a current ratio of 5.75, with a Debt / Equity ratio of 0.49.

Current Ratio	5.75
Quick Ratio	4.97
Debt / Equity	0.49
Debt / EBITDA	2.46
Debt / FCF	25.12
Interest Coverage	4.51

Financial Efficiency

Return on equity (ROE) is 9.63% and return on invested capital (ROIC) is 4.89%.

Return on Equity (ROE)	9.63%
Return on Assets (ROA)	4.31%
Return on Invested Capital (ROIC)	4.89%
Return on Capital Employed (ROCE)	7.84%
Revenue Per Employee	122,782
Profits Per Employee	12,565
Employee Count	157
Asset Turnover	0.58
Inventory Turnover	1.76

Taxes

In the past 12 months, Medicon Hellas has paid 378,133 in taxes.

Income Tax	378,133
Effective Tax Rate	17.37%

Stock Price Statistics

The stock price has increased by +19.71% in the last 52 weeks. The beta is 0.61, so Medicon Hellas's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	+19.71%
50-Day Moving Average	2.52
200-Day Moving Average	2.39
Relative Strength Index (RSI)	51.24
Average Volume (20 Days)	2,431

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicon Hellas had revenue of EUR 18.54 million and earned 1.90 million in profits. Earnings per share was 0.43.

Revenue	18.54M
Gross Profit	13.06M
Operating Income	2.22M
Pretax Income	2.18M
Net Income	1.90M
EBITDA	3.44M
EBIT	2.22M
Earnings Per Share (EPS)	0.43

Balance Sheet

The company has 9.01 million in cash and 9.41 million in debt, giving a net cash position of -401,442 or -0.09 per share.

Cash & Cash Equivalents	9.01M
Total Debt	9.41M
Net Cash	-401,442
Net Cash Per Share	-0.09
Equity (Book Value)	19.37M
Book Value Per Share	4.32
Working Capital	19.22M

Cash Flow

In the last 12 months, operating cash flow was 1.16 million and capital expenditures -789,211, giving a free cash flow of 374,744.

Operating Cash Flow	1.16M
Capital Expenditures	-789,211
Free Cash Flow	374,744
FCF Per Share	0.08

Margins

Gross margin is 70.43%, with operating and profit margins of 11.99% and 10.23%.

Gross Margin	70.43%
Operating Margin	11.99%
Pretax Margin	11.74%
Profit Margin	10.23%
EBITDA Margin	18.57%
EBIT Margin	11.99%
FCF Margin	2.02%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 5.16%.

Dividend Per Share	0.13
Dividend Yield	5.16%
Dividend Growth (YoY)	116.67%
Years of Dividend Growth	n/a
Payout Ratio	13.98%
Buyback Yield	n/a
Shareholder Yield	5.22%
Earnings Yield	17.04%
FCF Yield	3.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 28, 2004. It was a forward split with a ratio of 1.1.

Last Split Date	Jul 28, 2004
Split Type	Forward
Split Ratio	1.1

Scores

Medicon Hellas has an Altman Z-Score of 2.5 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.5
Piotroski F-Score	5